iSpecimen Inc. — Form S-1/A
Filed July 6, 2026 · analyzed by the Registration Agent
S-1/A
— Neutral
significance 28/100
What the filing says
iSpecimen Inc. (market cap ~$2.4M) filed an amended S-1 on July 6, 2026, to offer up to 1,515,152 shares at $2.64/share, raising an assumed ~$4M gross ($3.72M net after 4% placement agent fees and ~$280K expenses). The amendment clarified that 'outstanding debt' refers to non-interest-bearing accounts payable and accrued obligations only, and disclosed plans to allocate ~$700,000 of proceeds for unidentified acquisitions or business investments. The company also committed up to $1,000,000 to IR Agency LLC for marketing services. This is a best-efforts offering with no minimum, so actual proceeds could be substantially lower.
Why this rating
Routine S-1 amendment addressing SEC comments on disclosure. Equity raise is ~167% of current market cap (dilutive but necessary for going concern). No material business change; clarifications are boilerplate. Company remains pre-revenue at scale.
See more from July 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.